| Zheng, Yan sheng |
NCT05397587: An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) |
|
|
| Not yet recruiting | 4 | 474 | RoW | Experimental Vaccine, Enterovirus Type 71 Vaccine（Vero Cell）, Inactivated, Control Vaccine, Enterovirus Type 71 Vaccine, Inactivated（Human Diploid Cell） | Sinovac Biotech Co., Ltd | Hand, Foot and Mouth Disease | 07/25 | 10/25 | | |
NCT06041061: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years |
|
|
| Active, not recruiting | 3 | 18000 | RoW | Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）, placebo | Sinocelltech Ltd., Guangxi Center for Disease Control and Prevention, Henan Center for Disease Control and Prevention, Sichuan Center for Disease Control and Prevention, Shanxi Center for Disease Control and Prevention, Yunnan Center for Disease Control and Prevention | HPV InfectioN, HPV-Related Carcinoma | 03/24 | 08/28 | | |
| Recruiting | 3 | 189 | RoW | Roflumilast Cream 0.3%, Zoryve, Vehicle cream | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Plaque Psoriasis | 06/25 | 07/25 | | |
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 552 | RoW | ICP-332 Tablets, ICP-332 Placebo Tablets | Beijing InnoCare Pharma Tech Co., Ltd. | Atopic Dermatitis | 11/26 | 12/26 | | |
NCT05911841: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis |
|
|
| Active, not recruiting | 2 | 236 | Europe, Canada, Japan, US, RoW | LY3454738, Placebo | Eli Lilly and Company | Atopic Dermatitis | 06/25 | 03/26 | | |
| Recruiting | 1 | 140 | RoW | Sinovac PCV13, PREVNAR 13 | Sinovac Research and Development Co., Ltd. | Pneumococcal Infectious Disease | 02/25 | 07/25 | | |
